Career history
In the news
- Together with the team, I am extremely proud to share this important moment for MedEnvision. Our new partnership with TA Associates marks a major milestone, and we are grateful for the trust and commitment that made it possible. We are very much looking forward to building an ever-stronger company, one that supports orthopaedic surgeons in their daily mission to help patients worldwide move freely. Dries Goyens Chief Executive Officer MedEnvision TA Associates - Smile Invest
- TA is pleased to announce a strategic investment in MedEnvision, a Belgian medtech company. MedEnvision’s Efficient Surgery (ESY) solution, built around its Gripper™ and EsySuit™ products, standardizes workflows for hip, knee, and shoulder replacement procedures. As healthcare providers seek to improve outcomes and operational efficiency, we believe MedEnvision’s advanced technology and commitment to innovation position the Company well to meet the evolving needs of orthopedic surgical teams and hospitals. We look forward to
- Together with the team, I am extremely proud to share this important moment for MedEnvision. Our new partnership with TA Associates marks a major milestone, and we are grateful for the trust and commitment that made it possible. We are very much looking forward to building an ever-stronger company, one that supports orthopaedic surgeons in their daily mission to help patients worldwide move freely. Dries Goyens Chief Executive Officer MedEnvision Smile Invest - TA Associates
- We’re proud to share that TA Associates has agreed to invest in MedEnvision as its new majority shareholder. The existing shareholders (the founders, management and Smile Invest) are all reinvesting significantly. 🚀 Since we partnered in 2024, MedEnvision has accelerated its US growth, more than doubled its sales, strengthened its presence in more than 26 countries, and expanded its Efficient Surgery (ESY) solution (Gripper™, EsySuit™ and retractors) from hip to knee and shoulder surgery. These tools make orthopaedic surgery easier,
- We’re proud to share that TA Associates has agreed to invest in MedEnvision as its new majority shareholder. The existing shareholders (the founders, management and Smile Invest) are all reinvesting significantly. 🚀 Since we partnered in 2024, MedEnvision has accelerated its US growth, more than doubled its sales, strengthened its presence in more than 26 countries, and expanded its Efficient Surgery (ESY) solution (Gripper™, EsySuit™ and retractors) from hip to knee and shoulder surgery. These tools make orthopaedic surgery easier,
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.